David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk.
David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech.
David Stermanon
Analyst Articles
To the dismay of average investors, great companies such as Google Inc. (Nasdaq: GOOG), Priceline.com Inc. (Nasdaq: PCLN) and MasterCard (NYSE: MA) come with a steep price tag. Each has a stock price above $500, making it nearly impossible for small-time investors to… Read More
Even as you keep an eye on our ever-rising stock market, it also pays to monitor global economic trends. And looking at the economic reports coming out of Europe and China, there is a growing cause for… Read More
Peter Lynch, in his heyday with Fidelity Magellan fund‘s (Nasdaq: FMAGX), took a remarkably powerful yet simple approach to wealth-building: Avoid companies that provide products or services that are too hard for the layman to understand. Indeed, Lynch’s maxim, “Invest in what you… Read More
Even the brightest minds of the business world can make mistakes. The key is to spot those mistakes in a timely fashion and take corrective action.#-ad_banner-# That was on Jerome Peribere’s mind in August 2012, when he was hired as… Read More
Investing can be empowering — and not just because profits can free you from financial worry. Just a few decades ago, an investment strategy was key in the demise of one country’s segregationist political policies. Over time,… Read More
Wall Street analysts tend to provide an updated look at the companies they follow every month or two, ignoring short-term issues and trends on a week-to-week… Read More
The Dow Jones Industrial Average recently exceeded the previous record of 14,164 reached in October 2007. Of course, a number of components in the index returned to their peak much sooner and are now handily above levels seen in 2007. The best… Read More
When it comes to investing in biotech stocks, it’s wise to focus on companies that own drugs with a fairly large market opportunity. The bigger the potential… Read More
Gold versus silver. It’s a long-standing debate among precious-metal investors as to which commodity is a wiser investment. Both are seen as a hedge against… Read More
When assessing various investments, it’s wise to look at several factors. For example, are these investments capable of generating steady and predictable returns? Do they have solid growth prospects?#-ad_banner-#… Read More
